RIMLS VENI laureates 2016

Veni logo.jpg

Four young researchers, affiliated to the RIMLS, have each received a Veni grant of 250,000 Euro from the Netherlands Organization for Scientific Research (NWO). Our researchers received this prestigious grant for their remarkable and original talent and their ability to carry out innovative research. They have only recently completed their doctorates and have now the challenging opportunity to develop their scientific ideas during the coming three years. The Veni grant from the NWO's Innovational Research Incentives Scheme is one of the most prestigious grants for young researchers, and to be awarded is considered an important step in an academic career. Although the Veni researchers are at the beginning of their careers, they have demonstrated to not only possess a remarkable talent in conducting academic research, but are also at the top of their scientific field internationally.

As RIMLS we can make the difference with these newly identified high potentials who can start their own research lines. Hopefully, they will also serve as role models for our current PhD's and motivate them to pursue a similar Veni track

During the application process our Veni applicants were supported by the RIMLS Grant Committee chaired by Johan van der Vlag and our Valorisation Centre. Their successful support is greatly appreciated and certainly contributed to this outstanding achievement.

On behalf of all RIMLS colleagues, we wish our laureates a lot of fun and excitement performing their studies and outlined plans in the years to come. Congratulations to all of you! 

RIMLS-related Awardees:


undefinedundefinedMarije Doppenberg-Oosting, Dept. of Experimental Internal Medicine

Title of the project:  Put the brake on Borrelia-induced joint inflammation.

Aim of the project: After recognition of pathogens, including Borrelia bacteria, our immune system is activated to kill the invaders. The role of one of these recognizers (TLR10) will be determined, because TLR10 has the unique capacity to inhibit other TLRs. TLR10 might therefore be used in the treatment of Lyme disease.  

 

undefinedSandra Heskamp, Dept. of Radiology and Nuclear Medicine

Title of the project: Towards better patient selection for immune checkpoint inhibitor therapy for cancer: imaging of the PD-L1 and PD-1 pathway

Aim of the project: Immune checkpoint inhibitors are novel, promising anti-cancer agents. However, not all patients benefit from these expensive drugs. Sandra will develop novel imaging techniques to predict on beforehand which patients will respond. This will improve the chance of effective treatment and reduce unnecessary side effects and health care costs.

undefinedNatalia Revelo Nuncira, Dept. of Tumor Immunology

Title of the project: Turning on the alarms: how dendritic cells activate the immune attack    

Aim of the project: Dendritic cells scan our bodies searching for pathogens and cancer cells. After finding a threat, they deliver an alarm message to specialized immune cells trained to keep the danger under control. Natalia will use high-resolution microscopes to understand how dendritic cells prepare, pack and deliver this alarm message.  

undefinedNelleke Spruijt, dept. of Molecular Biology

Title of the project:  NuRD regulates development 

Aim of the project: Nelleke will use a mass measuring machine to study which proteins are in the NuRD complex together. This protein complex plays an important role during the development of blood cells. She will investigate which genes are regulated by NuRD during this development.

 


 

 


<< back to overview news items